CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,563,798
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,563,798. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-06 | Trimarchi Thomas President and COO | Grant or award | +19,003 | 413,859 | ||
| 2024-08-06 | Trimarchi Thomas President and COO | Grant or award · Stock Option (Right to Buy) | +3,160 | 3,160 | ||
| 2024-06-21 | Valantine Hannah Director | Grant or award · Stock Option (Right to Buy) | +26,014 | 26,014 | ||
| 2024-06-21 | Scott Randal W. Director | Grant or award · Stock Option (Right to Buy) | +26,014 | 26,014 | ||
| 2024-06-21 | Satvat Ali J. Director | Grant or award · Stock Option (Right to Buy) | +26,014 | 26,014 | ||
| 2024-06-21 | MOMTAZEE JAMES C Director | Grant or award · Stock Option (Right to Buy) | +26,014 | 26,014 | ||
| 2024-06-21 | MCCORMICK FRANK Director | Grant or award · Stock Option (Right to Buy) | +26,014 | 26,014 | ||
| 2024-06-21 | Lo Andrew Director | Grant or award · Stock Option (Right to Buy) | +26,014 | 26,014 | ||
| 2024-06-21 | HOMCY CHARLES J Director | Grant or award · Stock Option (Right to Buy) | +26,014 | 26,014 | ||
| 2024-06-21 | Hassan Fred Director | Grant or award · Stock Option (Right to Buy) | +26,014 | 26,014 | ||
| 2024-06-21 | Ellis Andrea Director | Grant or award · Stock Option (Right to Buy) | +26,014 | 26,014 | ||
| 2024-06-21 | DANIELS RONALD J Director | Grant or award · Stock Option (Right to Buy) | +26,014 | 26,014 | ||
| 2024-06-21 | Dachille Douglas A. Director | Grant or award · Stock Option (Right to Buy) | +26,014 | 26,014 | ||
| 2024-06-21 | Cook Jennifer E. Director | Grant or award · Stock Option (Right to Buy) | +26,014 | 26,014 | ||
| 2024-06-21 | AGUIAR ERIC Director | Grant or award · Stock Option (Right to Buy) | +26,014 | 26,014 | ||
| 2024-06-04 | Scott Randal W. Director | Sale 10b5-1 | −1,500 | $31.30 | $47K | 4,000 |
| 2024-06-03 | Scott Randal W. Director | Sale 10b5-1 | −800 | $28.68 | $23K | 5,700 |
| 2024-06-03 | Scott Randal W. Director | Sale 10b5-1 | −200 | $29.48 | $6K | 5,500 |
| 2024-05-16 | Kumar Neil CEO and President | Option exercise | +60,667 | 4,928,191 | ||
| 2024-05-16 | Kumar Neil CEO and President | Shares withheld for taxes | −30,748 | $31.04 | $954K | 4,897,443 |
Page 24 of 32 · 638 trades